Effectiveness of a bedaquiline, linezolid, clofazimine 'core' for multidrug-resistant TB.

Saved in:
Bibliographic Details
Title: Effectiveness of a bedaquiline, linezolid, clofazimine 'core' for multidrug-resistant TB.
Authors: Zeng C; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Hernán MA; CAUSALab, Departments of Epidemiology and Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Trevisi L; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Sauer S; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Mitnick CD; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.; Partners In Health (PIH), Boston, MA, USA.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA., Hewison C; Medical Department, Médecins Sans Frontières (MSF), Paris, France., Bastard M; Field Epidemiology Department, Epicentre, Paris, France., Khan P; Interactive Research and Development (IRD) Global, Singapore.; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK., Seung KJ; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.; Partners In Health (PIH), Boston, MA, USA.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA., Rich ML; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.; Partners In Health (PIH), Boston, MA, USA.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA., Law S; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Kikvidze M; MSF, Sokhumi, Georgia., Kirakosyan O; MSF, Yerevan, Armenia., Miankou A; MSF, Minsk, Belarus., Thit P; MSF, Yangon, Myanmar., Mamsa S; Indus Hospital & Health Network (IHHN), Karachi, Pakistan., Janmohamed A; Interactive Research and Development, Karachi, Pakistan., Melikyan N; Field Epidemiology Department, Epicentre, Paris, France., Ahmed S; Interactive Research and Development, Karachi, Pakistan., Vargas D; PIH/Socios En Salud Sucursal Peru, Lima, Peru., Binegdie AB; Addis Ababa University College of Health Sciences, Department of Internal Medicine, Addis Ababa, Ethiopia., Temirova K; PIH, Almaty, Kazakhstan., Oyewusi L; PIH, Lesotho, Maseru, Lesotho., Philippe K; PIH, Port-au-Prince, Haiti., Vilbrun SC; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Khan U; Interactive Research and Development (IRD) Global, Singapore., Huerga H; Field Epidemiology Department, Epicentre, Paris, France., Franke MF; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Source: IJTLD open [IJTLD Open] 2025 May 12; Vol. 2 (5), pp. 269-275. Date of Electronic Publication: 2025 May 12 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: International Union against Tuberculosis and Lung Disease Country of Publication: France NLM ID: 9918803487706676 Publication Model: eCollection Cited Medium: Internet ISSN: 3005-7590 (Electronic) Linking ISSN: 30057590 NLM ISO Abbreviation: IJTLD Open Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:3005-7590
DOI:10.5588/ijtldopen.24.0515